OBJECTIVE: The ability to noninvasively monitor the development of inflammatory arthritis longitudinally has become increasingly important in experimental rheumatology. Magnetic resonance imaging (MRI) allows for detailed examination of anatomic structures, as well as the assessment of joint and soft tissue inflammation. The aim of this study was to extend the use of MRI to include quantitative measurements of bone destruction in murine ankle joints. METHODS: Joint disease was measured serially using clinical, histologic, in vivo imaging system (IVIS), micro-computed tomography (micro-CT), and MRI techniques in mouse ankle joints, using the K/BxN serum transfer-induced acute arthritis and K/BxA(g7) chronic arthritis models. Ankle joint MRI was performed using a gradient-echo pulse sequence to evaluate bone destruction and a spin-echo sequence to evaluate inflammation (long T2 signal). RESULTS: Arthritic mice, as compared to control mice, demonstrated increased disease severity according to clinical, histologic, IVIS, and MRI measures. Following induction of arthritis, the majority of volume expansion of the long T2 signal occurred in a juxtaarticular, rather than intrarticular, manner within the ankle joints. Bone destruction in K/BxA(g7) mouse ankle joints was readily detectible by MRI. Linear regression analyses demonstrated significant correlations between the clinical score and joint radiance intensity assessed by IVIS, between the ankle joint width and increased long T2 signal on MRI, and between the bone volume obtained by micro-CT and bone volume obtained by MRI. CONCLUSION: MRI is an optimal technology for anatomic localization of articular and soft tissue changes during the development and progression of inflammatory arthritis. Future studies may combine MRI with in vivo labeling agents to investigate joint disease in a cell type-specific manner.
OBJECTIVE: The ability to noninvasively monitor the development of inflammatory arthritis longitudinally has become increasingly important in experimental rheumatology. Magnetic resonance imaging (MRI) allows for detailed examination of anatomic structures, as well as the assessment of joint and soft tissue inflammation. The aim of this study was to extend the use of MRI to include quantitative measurements of bone destruction in murineankle joints. METHODS:Joint disease was measured serially using clinical, histologic, in vivo imaging system (IVIS), micro-computed tomography (micro-CT), and MRI techniques in mouseankle joints, using the K/BxN serum transfer-induced acute arthritis and K/BxA(g7) chronic arthritis models. Ankle joint MRI was performed using a gradient-echo pulse sequence to evaluate bone destruction and a spin-echo sequence to evaluate inflammation (long T2 signal). RESULTS: Arthritic mice, as compared to control mice, demonstrated increased disease severity according to clinical, histologic, IVIS, and MRI measures. Following induction of arthritis, the majority of volume expansion of the long T2 signal occurred in a juxtaarticular, rather than intrarticular, manner within the ankle joints. Bone destruction in K/BxA(g7) mouseankle joints was readily detectible by MRI. Linear regression analyses demonstrated significant correlations between the clinical score and joint radiance intensity assessed by IVIS, between the ankle joint width and increased long T2 signal on MRI, and between the bone volume obtained by micro-CT and bone volume obtained by MRI. CONCLUSION: MRI is an optimal technology for anatomic localization of articular and soft tissue changes during the development and progression of inflammatory arthritis. Future studies may combine MRI with in vivo labeling agents to investigate joint disease in a cell type-specific manner.
Authors: A S Korganow; H Ji; S Mangialaio; V Duchatelle; R Pelanda; T Martin; C Degott; H Kikutani; K Rajewsky; J L Pasquali; C Benoist; D Mathis Journal: Immunity Date: 1999-04 Impact factor: 31.745
Authors: Nathaniel J Brown; Jack Hutcheson; Emily Bickel; John C Scatizzi; Lee D Albee; G Kenneth Haines; Joy Eslick; Kathleen Bradley; Elsa Taricone; Harris Perlman Journal: J Immunol Date: 2004-12-15 Impact factor: 5.422
Authors: N Saidenberg-Kermanac H; F Leclercq; J Herscovici; D Scherman; M C Boissier Journal: Clin Exp Rheumatol Date: 2006 Mar-Apr Impact factor: 4.473
Authors: R D Kapadia; G B Stroup; A M Badger; B Koller; J M Levin; R W Coatney; R A Dodds; X Liang; M W Lark; M Gowen Journal: Technol Health Care Date: 1998-12 Impact factor: 1.285
Authors: John C Scatizzi; Jack Hutcheson; Emily Bickel; James M Woods; Karolina Klosowska; Terry L Moore; G Kenneth Haines; Harris Perlman Journal: Am J Pathol Date: 2006-05 Impact factor: 4.307
Authors: Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Laura M Calvi; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz Journal: Arthritis Rheum Date: 2008-07
Authors: Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz Journal: Arthritis Rheum Date: 2007-12
Authors: Shimon Gross; Seth T Gammon; Britney L Moss; Daniel Rauch; John Harding; Jay W Heinecke; Lee Ratner; David Piwnica-Worms Journal: Nat Med Date: 2009-03-22 Impact factor: 53.440
Authors: Beth Friedman; Michael A Whitney; Elamprakash N Savariar; Christa Caneda; Paul Steinbach; Qing Xiong; Dina V Hingorani; Jessica Crisp; Stephen R Adams; Michael Kenner; Csilla N Lippert; Quyen T Nguyen; Monica Guma; Roger Y Tsien; Maripat Corr Journal: Arthritis Rheumatol Date: 2017-11-29 Impact factor: 10.995
Authors: Michal B Gutowski; Leslie Wilson; Russell N Van Gelder; Kathryn L Pepple Journal: Invest Ophthalmol Vis Sci Date: 2017-03-01 Impact factor: 4.799
Authors: Bálint Botz; Gábor Kriszta; Kata Bölcskei; Ádám István Horváth; Attila Mócsai; Zsuzsanna Helyes Journal: Int J Mol Sci Date: 2021-02-08 Impact factor: 5.923